Joan R Cates1, Sandra J Diehl2, Jamie L Crandell3, Tamera Coyne-Beasley4. 1. School of Journalism and Mass Communication, University of North Carolina at Chapel Hill, Campus Box 3365, Chapel Hill, NC 27599-3365, United States. Electronic address: JoanCates@unc.edu. 2. NC TraCS Institute, Community Academic Resources for Engaged Scholarship (CARES), Home of the UNC Clinical and Translational Science Awards (CTSA), University of North Carolina at Chapel Hill, CB# 7064, Chapel Hill, NC 27599-7064, United States. Electronic address: diehl@unc.edu. 3. School of Nursing and Department of Biostatistics, University of North Carolina at Chapel Hill, 2011 Carrington Hall, Campus Box 7460, Chapel Hill, NC 27599-7460, United States. Electronic address: jbigelow@unc.edu. 4. NC Child Health Research Network, Community Engagement NC TraCS Institute - Child Health Core Home of the UNC-CH Clinical and Translational Science Awards (CTSA), United States; Division of General Pediatrics and Adolescent Medicine, University of North Carolina at Chapel Hill, CB # 7225, 231 MacNider, Chapel Hill, NC 27599, United States. Electronic address: tamera_coyne-beasley@med.unc.edu.
Abstract
OBJECTIVES: Adoption of human papillomavirus (HPV) vaccination in the US has been slow. In 2011, HPV vaccination of boys was recommended by CDC for routine use at ages 11-12. We conducted and evaluated a social marketing intervention with parents and providers to stimulate HPV vaccination among preteen boys. METHODS: We targeted parents and providers of 9-13 year old boys in a 13 county NC region. The 3-month intervention included distribution of HPV vaccination posters and brochures to all county health departments plus 194 enrolled providers; two radio PSAs; and an online CME training. A Cox proportional hazards model was fit using NC immunization registry data to examine whether vaccination rates in 9-13 year old boys increased during the intervention period in targeted counties compared to control counties (n=15) with similar demographics. To compare with other adolescent vaccines, similar models were fit for HPV vaccination in girls and meningococcal and Tdap vaccination of boys in the same age range. Moderating effects of age, race, and Vaccines for Children (VFC) eligibility on the intervention were considered. RESULTS: The Cox model showed an intervention effect (β=0.29, HR=1.34, p=.0024), indicating that during the intervention the probability of vaccination increased by 34% in the intervention counties relative to the control counties. Comparisons with HPV vaccination in girls and Tdap and meningococcal vaccination in boys suggest a unique boost for HPV vaccination in boys during the intervention. Model covariates of age, race and VFC eligibility were all significantly associated with vaccination rates (p<.0001 for all). HPV vaccination rates were highest in the 11-12 year old boys. Overall, three of every four clinic visits for Tdap and meningococcal vaccines for preteen boys were missed opportunities to administer HPV vaccination simultaneously. CONCLUSIONS: Social marketing techniques can encourage parents and health care providers to vaccinate preteen boys against HPV.
OBJECTIVES: Adoption of human papillomavirus (HPV) vaccination in the US has been slow. In 2011, HPV vaccination of boys was recommended by CDC for routine use at ages 11-12. We conducted and evaluated a social marketing intervention with parents and providers to stimulate HPV vaccination among preteen boys. METHODS: We targeted parents and providers of 9-13 year old boys in a 13 county NC region. The 3-month intervention included distribution of HPV vaccination posters and brochures to all county health departments plus 194 enrolled providers; two radio PSAs; and an online CME training. A Cox proportional hazards model was fit using NC immunization registry data to examine whether vaccination rates in 9-13 year old boys increased during the intervention period in targeted counties compared to control counties (n=15) with similar demographics. To compare with other adolescent vaccines, similar models were fit for HPV vaccination in girls and meningococcal and Tdap vaccination of boys in the same age range. Moderating effects of age, race, and Vaccines for Children (VFC) eligibility on the intervention were considered. RESULTS: The Cox model showed an intervention effect (β=0.29, HR=1.34, p=.0024), indicating that during the intervention the probability of vaccination increased by 34% in the intervention counties relative to the control counties. Comparisons with HPV vaccination in girls and Tdap and meningococcal vaccination in boys suggest a unique boost for HPV vaccination in boys during the intervention. Model covariates of age, race and VFC eligibility were all significantly associated with vaccination rates (p<.0001 for all). HPV vaccination rates were highest in the 11-12 year old boys. Overall, three of every four clinic visits for Tdap and meningococcal vaccines for preteen boys were missed opportunities to administer HPV vaccination simultaneously. CONCLUSIONS: Social marketing techniques can encourage parents and health care providers to vaccinate preteen boys against HPV.
Authors: Ross C Brownson; Julie A Jacobs; Rachel G Tabak; Christine M Hoehner; Katherine A Stamatakis Journal: Am J Public Health Date: 2013-07-18 Impact factor: 9.308
Authors: Susan T Vadaparampil; Jessica A Kahn; Daniel Salmon; Ji-Hyun Lee; Gwendolyn P Quinn; Richard Roetzheim; Karen Bruder; Teri L Malo; Tina Proveaux; Xiuhua Zhao; Neal Halsey; Anna R Giuliano Journal: Vaccine Date: 2011-09-14 Impact factor: 3.641
Authors: Jennifer D Allen; Gloria D Coronado; Rebecca S Williams; Beth Glenn; Cam Escoffery; Maria Fernandez; Raegan A Tuff; Katherine M Wilson; Patricia Dolan Mullen Journal: Vaccine Date: 2010-04-20 Impact factor: 3.641
Authors: Lauri E Markowitz; Susan Hariri; Carol Lin; Eileen F Dunne; Martin Steinau; Geraldine McQuillan; Elizabeth R Unger Journal: J Infect Dis Date: 2013-06-19 Impact factor: 5.226
Authors: Richard K Zimmerman; Krissy K Moehling; Chyongchiou J Lin; Song Zhang; Jonathan M Raviotta; Evelyn C Reis; Sharon G Humiston; Mary Patricia Nowalk Journal: Vaccine Date: 2016-11-18 Impact factor: 3.641
Authors: Joan R Cates; Sandra J Diehl; Bernard F Fuemmeler; Stephen W North; Richard J Chung; Jill Forcina Hill; Tamera Coyne-Beasley Journal: J Public Health Manag Pract Date: 2020 Mar/Apr
Authors: Stephanie A S Staras; Susan T Vadaparampil; Melvin D Livingston; Lindsay A Thompson; Ashley H Sanders; Elizabeth A Shenkman Journal: J Adolesc Health Date: 2015-05 Impact factor: 5.012
Authors: May Rose Isnec Dela Cruz; Kathryn L Braun; Jo Ann Umilani Tsark; Cheryl Lynn Albright; John J Chen Journal: Ethn Health Date: 2018-05-10 Impact factor: 2.772